investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Dennis Klinman

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides 

Trachea, bronchus and lung

Raymond B Birge

Non-canonical signal pathway for Crk in breast cancer

Trachea, bronchus and lung

Alan P Fields

Protein Kinase C Signaling Mechanisms in Cancer

Trachea, bronchus and lung

Pathology

Munira Basrai

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

Trachea, bronchus and lung

Jennifer Brady

Mechanisms governing tumor differentiation and metastasis

Trachea, bronchus and lung

Pathology

Piro Lito

Elucidating the regulation of mitosis by BRAF V600E in lung cancer

Trachea, bronchus and lung

Saikrishna Yendamuri

MicroRNA profiling to predict recurrence after resection of early lung cancer

Trachea, bronchus and lung

David A Barbie

Targeting the cytokine circuitry of KRAS-driven lung cancer

Trachea, bronchus and lung

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Trachea, bronchus and lung

Radiation Oncology